CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction Genotyping to Guide Clopidogrel Treatment: An In-Depth Analysis of the TAILOR-PCI Trial Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation

ConsensusOctober 10, 2017, Volume 136, Issue 15

JOURNAL:Circulation. Article Link

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

AHA Scientific Statements Keywords: AHA Scientific Statements; delivery of health care; disease management; shock, cardiogenic

ABSTRACT

Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure. Despite improving survival in recent years, patient morbidity and mortality remain high, and there are few evidence-based therapeutic interventions known to clearly improve patient outcomes. This scientific statement on cardiogenic shock summarizes the epidemiology, pathophysiology, causes, and outcomes of cardiogenic shock; reviews contemporary best medical, surgical, mechanical circulatory support, and palliative care practices; advocates for the development of regionalized systems of care; and outlines future research priorities.